Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

ATHA Athira Pharma Inc

0,5311

-0,034 (-6,02%)

Nach Börsenschluss

Zuletzt aktualisiert: 23:30:30

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Athira Pharma (NASDAQ:ATHA)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Athira Pharma Charts.

Athira Pharma (NASDAQ:ATHA)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Athira Pharma Charts.

News Athira Pharma Inc

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 3 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 3 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 3 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND
Freitag 6 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates
Donnerstag 7 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Dienstag 29 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Meeting
Dienstag 22 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Montag 21 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Athira Pharma Inc News-Artikel

Financial Select Sector

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen